tenofovir disoproxil succinate - medicine shortage information

Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Sort by: Updated date | Shortage status | Trade name

Product details	Supply Impact Dates	Further Details
TENOFOVIR / EMTRICITABINE SANDOZ 301/200 tenofovir disoproxil succinate / emtricitabine 301 mg/200 mg film-coated tablet bottle AUST R: 326237 Active ingredients: emtricitabine tenofovir disoproxil succinate Dosage form: Tablet, film coated Sponsor: Sandoz Pty Ltd Phone: 1800726369	Deletion from market: 20 May 2026	Shortage status: Discontinued Availability: Unavailable Reason: Manufacturing Management action: This product is being replaced by TENOFOVIR/EMTRICITABINE SANDOZ PHARMA 300/200 tenofovir disoproxil fumarate 300 mg and emtricitabine 200 mg tablet bottle pack (ARTG 475545). Alternative brands are available to cover for any gaps in supply.

Product details

Supply Impact Dates

Further Details

TENOFOVIR / EMTRICITABINE SANDOZ 301/200 tenofovir disoproxil succinate / emtricitabine 301 mg/200 mg film-coated tablet bottle
AUST R: 326237
Active ingredients:
emtricitabine
tenofovir disoproxil succinate

Dosage form:
Tablet, film coated

Sponsor:
Sandoz Pty Ltd

Phone:
1800726369

Deletion from market:
20 May 2026

Shortage status:
Discontinued

Availability:
Unavailable

Reason:
Manufacturing

Management action:
This product is being replaced by TENOFOVIR/EMTRICITABINE SANDOZ PHARMA 300/200 tenofovir disoproxil fumarate 300 mg and emtricitabine 200 mg tablet bottle pack (ARTG 475545). Alternative brands are available to cover for any gaps in supply.